Welcome to JAR Pharmaceuticals
Delivery by design. Proudly Canadian since 1987.
We specialize in developing advanced topical gels and creams that enhance skin texture and improve drug delivery through innovative lecithin organogel technology. Dedicated to high standards, we provide comprehensive support and superior products to physicians, pharmacists, and patients, ensuring exceptional quality and service.
Our Solutions
.jpeg)
.jpeg)
PHLOJEL® Synergy 3:1
PHLOJEL® Synergy 3:1 is a lecithin organogel designed for transdermal drug delivery. Its unique 3:1 hydrophilic to organic ratio ensures balanced absorption and effective medication release. This gel is ideal for targeted therapy, offering stable, consistent performance while maintaining a smooth application.
Founded in 1987 by Dr. James A. Rogers, PhD, J.A.R. Pharmaceuticals Ltd. set out to transform how medications are delivered with a focus on bypassing gastrointestinal side effects associated with oral arthritis treatments. Our pioneering use of liposome technology led to the creation of PHLOJEL®, a breakthrough in topical medication delivery.
Building on this success, we introduced PHLOJEL® Ultra, enhancing our formula for even more effective transdermal absorption. The culmination of our innovations led to the creation of PHLODERM™, a state-of-the-art moisturizer that deeply hydrates and restores the skin's natural barrier beyond the top layer, designed for individuals with severe dry skin conditions.
J.A.R. Pharmaceuticals continues to lead with science-driven solutions that prioritize patient care and product efficacy.
